Benzenesulfonamides
Sigma Aldrich Fine Chemicals Biosciences Gliclazide powder, >=98% | 21187-98-4 | MFCD00409893 | 5G
Gliclazide powder, >=98% | Purity: >=98% | Mol Wt: 323.41 | 21187-98-4 | MFCD00409893 | 5G
Sigma Aldrich Fine Chemicals Biosciences Sildenafil citrate European Pharmacopoeia (EP) Reference Standard | 171599-83-0 | MFCD09026931 |
Sildenafil citrate European Pharmacopoeia (EP) Reference Standard | Mol Wt: 666.7 | 171599-83-0 | MFCD09026931 |
Sigma Aldrich Fine Chemicals Biosciences GSK137647A >=98% (HPLC) | 349085-82-1 | MFCD02007969 | 5MG
GSK137647A >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 305.39 | 349085-82-1 | MFCD02007969 | 5MG
Sigma Aldrich Fine Chemicals Biosciences Tamsulosin hydrochloride >=98% (HPLC) | 106463-17-6 | MFCD00922997 | 50MG
Tamsulosin hydrochloride >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 444.97 | 106463-17-6 | MFCD00922997 | 50MG
Sigma Aldrich Fine Chemicals Biosciences Clopamide for system suitability European Pharmacopoeia (EP) Reference Standard | 636-54-4 | MFCD00941495 |
Clopamide for system suitability European Pharmacopoeia (EP) Reference Standard | Mol Wt: 345.84 | 636-54-4 | MFCD00941495 |
Sigma Aldrich Fine Chemicals Biosciences Glimepiride United States Pharmacopeia (USP) Reference Standard | 93479-97-1 | MFCD00878417 | 200MG
Glimepiride United States Pharmacopeia (USP) Reference Standard | Mol Wt: 490.62 | 93479-97-1 | MFCD00878417 | 200MG
Sigma Aldrich Fine Chemicals Biosciences Tamsulosin hydrochloride European Pharmacopoeia (EP) Reference Standard | 106463-17-6 | MFCD00922997 |
Tamsulosin hydrochloride European Pharmacopoeia (EP) Reference Standard | Mol Wt: 444.97 | 106463-17-6 | MFCD00922997 |
Sigma Aldrich Fine Chemicals Biosciences Valdecoxib >=98% (HPLC) | 181695-72-7 | MFCD00950568 | 25MG
Valdecoxib >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 314.36 | 181695-72-7 | MFCD00950568 | 25MG
Cayman Chemical GlImepIrIde 500mg
An inhibitor of SUR1/Kir6.2, SUR2A/Kir6.2, and SUR2B/Kir6.2 (IC50s = 3, 5.4, and 7.3 nM, respectively, in Xenopus oocytes expressing the mouse receptor); induces InsR complex dissociation and insulin degradation in HepG2 cells at 20 µM; decreases blood glucose and plasma insulin levels in a KKAy mouse model of insulin-resistant type 2 diabetes at 0.05 mg/kg per day; reduces HbA1c levels in the same model at 0.5 mg/kg per day
Sigma Aldrich Fine Chemicals Biosciences Glimepiride >=98% (HPLC), solid | 93479-97-1 | MFCD00878417 | 250MG
Glimepiride >=98% (HPLC), solid | Purity: >=98% (HPLC) | Mol Wt: 490.62 | 93479-97-1 | MFCD00878417 | 250MG
Sigma Aldrich Fine Chemicals Biosciences Gliclazide impurity F European Pharmacopoeia (EP) Reference Standard | 1076198-18-9 |
Gliclazide impurity F European Pharmacopoeia (EP) Reference Standard | Mol Wt: 323.41 | 1076198-18-9 |
Sigma Aldrich Fine Chemicals Biosciences TMI-1 >=98% (HPLC) | 287403-39-8 | 5MG
TMI-1 >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 398.5 | 287403-39-8 | 5MG
eMolecules 871329-59-8 | N,N-Dimethyl 3-boronobenzenesulfonamide | Combi-Blocks | MFCD07363747 | 229.060 | C8H12BNO4S | 98.000 | CN(C)S(=O)(=O)c1cccc(c1)B(O)O | 1g | 117521009
N,N-Dimethyl 3-boronobenzenesulfonamide | Combi-Blocks | 871329-59-8 | MFCD07363747 | 229.060 | C8H12BNO4S | 98.000 | CN(C)S(=O)(=O)c1cccc(c1)B(O)O | 1g | 117521009
Sigma Aldrich Fine Chemicals Biosciences furosemide for peak identi
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.for further information and support please go to the website of the issuing Pharmacopoeia.